Partnering with 
One in 10 people over the age of 65 is living with Alzheimer’s disease (AD)—and there is no cure. New research shows that certain edits of the brain’s genetic blueprint may underlie the disease. Learn how existing FDA-approved medicines may offer near-term hope to treat this devastating type of dementia.
Speaker
Professor
Degenerative Diseases Program
Senior Vice President
Neuroscience Drug Discovery
Neuroscience and Aging Research Center